CY1457A - Use of anticholinergic drugs - Google Patents

Use of anticholinergic drugs Download PDF

Info

Publication number
CY1457A
CY1457A CY1457A CY145789A CY1457A CY 1457 A CY1457 A CY 1457A CY 1457 A CY1457 A CY 1457A CY 145789 A CY145789 A CY 145789A CY 1457 A CY1457 A CY 1457A
Authority
CY
Cyprus
Prior art keywords
scopolamine
drug
therapeutic system
releases
continuously
Prior art date
Application number
CY1457A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of CY1457A publication Critical patent/CY1457A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY1457A 1980-11-12 1989-07-21 Use of anticholinergic drugs CY1457A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH839180 1980-11-12

Publications (1)

Publication Number Publication Date
CY1457A true CY1457A (en) 1989-07-21

Family

ID=4339605

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1457A CY1457A (en) 1980-11-12 1989-07-21 Use of anticholinergic drugs

Country Status (13)

Country Link
EP (1) EP0052074B1 (fr)
JP (1) JPS57114508A (fr)
BE (1) BE891069A (fr)
CY (1) CY1457A (fr)
DE (2) DE3175894D1 (fr)
GB (1) GB2087234B (fr)
HK (1) HK4889A (fr)
IT (1) IT1172052B (fr)
MY (1) MY8700681A (fr)
NL (1) NL8104929A (fr)
NZ (1) NZ198942A (fr)
PH (1) PH19066A (fr)
ZA (1) ZA817796B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
AU592322B2 (en) * 1984-10-11 1990-01-11 Key Pharmaceuticals, Inc. Physiological means of enhancing transdermal delivery of drugs
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
JP2001267000A (ja) 2000-03-21 2001-09-28 Sumitomo Wiring Syst Ltd 防水コネクタ
JO3510B1 (ar) * 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
JP6073231B2 (ja) * 2011-08-31 2017-02-01 興和株式会社 安定な医薬組成物
JP2017014292A (ja) * 2016-10-24 2017-01-19 ロート製薬株式会社 医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally

Also Published As

Publication number Publication date
JPS57114508A (en) 1982-07-16
HK4889A (en) 1989-01-27
PH19066A (en) 1985-12-17
MY8700681A (en) 1987-12-31
EP0052074A3 (en) 1983-04-13
IT8149667A1 (it) 1983-05-10
NZ198942A (en) 1991-04-26
DE3175894D1 (en) 1987-03-12
JPH0150683B2 (fr) 1989-10-31
ZA817796B (en) 1982-10-27
EP0052074B1 (fr) 1987-02-04
NL8104929A (nl) 1982-06-01
GB2087234B (en) 1986-06-25
IT1172052B (it) 1987-06-18
BE891069A (fr) 1982-05-10
DE3144504A1 (de) 1982-06-24
GB2087234A (en) 1982-05-26
IT8149667A0 (it) 1981-11-10
EP0052074A2 (fr) 1982-05-19

Similar Documents

Publication Publication Date Title
DK175375B1 (da) Lamineret komposit til transdermal administration af fentanyl
EP0498468B1 (fr) Dispositif pour l'administration de nicotine par voie transcutanée
US5186939A (en) Laminated composite for transdermal administration of fentanyl
US4704119A (en) Method comprising transdermal and buccal treatment of angina
AU621952B2 (en) Dosage form having reduced abuse potential
US4650484A (en) Method for treating ischemic conditions
US4486193A (en) Method for treating ischemic conditions by administering drug by two routes
EP0431519A1 (fr) Système pour l'administration transdermale d'albutérol
US4262003A (en) Method and therapeutic system for administering scopolamine transdermally
Arndts et al. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine
WO2008021113A2 (fr) Méthodes transdermiques et systèmes pour traiter la maladie d'alzheimer
JPS63233916A (ja) 弾力性経皮薬剤供給デバイス，およびアルカンジオールの脂肪酸エステル／エーテルを経皮吸収促進剤とする組成物およびデバイス
WO2001008681A1 (fr) Methodes d'administration de compositions de glycopyrrolates
US4956181A (en) Nitrate therapy for angina pectoris
GB2087234A (en) Anticholinergic drugs/ transdermal skin plasters
EP0900076B1 (fr) Dispositif transdermique
JP2002532540A (ja) 透明な経皮的ニコチン送達デバイス
CA1309661C (fr) Systeme d'administration transdermiques
EP1652523A1 (fr) Preparation pour absorption transdermique
EP0306926A2 (fr) Pansement contenant du salbutamol et méthode pour sa production
JPH01299217A (ja) 硬膏剤
JPH04273818A (ja) 経皮投与製剤
US4846826A (en) Method for treating ischemic conditions
KR100543124B1 (ko) 약물에 의한 피부 자극 또는 감작화의 경감 또는 방지용 약학적 조성물
CA2028256A1 (fr) Systeme d'administration de medicaments transdermique a couches multiples